Wenfang He
About
In The Last Decade
Wenfang He
49 papers receiving 644 citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 375
- Cancer Research 109
- Pulmonary and Respiratory Medicine 95
- Epidemiology 76
- Nephrology 72
Countries citing papers authored by Wenfang He
This map shows the geographic impact of Wenfang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfang He more than expected).
Fields of papers citing papers by Wenfang He
This network shows the impact of papers produced by Wenfang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfang He. The network helps show where Wenfang He may publish in the future.
Co-authorship network of co-authors of Wenfang He
This figure shows the co-authorship network connecting the top 25 collaborators of Wenfang He. A scholar is included among the top collaborators of Wenfang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfang He. Wenfang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 14 | |
| 7 | 15 | |
| 8 | 1 | |
| 9 | 15 | |
| 10 | 12 | |
| 11 | 8 | |
| 12 | 3 | |
| 13 | 17 | |
| 14 | 52 | |
| 15 | 1 | |
| 16 | 2 | |
| 17 | 3 | |
| 18 | 60 | |
| 19 | 13 | |
| 20 | Chinese herbal extract dl-3n-butylphthalide: A commonly used drug for the treatment of ischemic stroke as a novel therapeutic approach to treat neurodegenerative diseases | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.